Risk of Nonmelanoma Skin Cancer Associated With Exposure to Ruxolitinib
Results of a 10-year retrospective study suggests a higher risk of nonmelanoma skin cancer in patients with PV or MF after ruxolitinib exposure.
Myeloproliferative Neoplasms
Excess Mortality Higher in Younger Patients With MPNs vs Older Patients
Excess all-cause mortality was greater in younger patients with essential thrombocythemia, polycythemia vera, and primary myelofibrosis.
Seroconversion After COVID-19 Vaccination High in CML, Low in NHL
Seroconversion was observed in 99% of patients with chronic myeloid leukemia.
Besremi Approved for Adults With Polycythemia Vera
Besremi is a monopegylated, long-acting interferon, which exhibits its cellular effects in the bone marrow in polycythemia vera.
Research Assessment Seeks Evidence to Guide Treatment of MPN With COVID-19
Investigators assessed studies for evidence to guide the management of MPN in patients with COVID-19.
Parsaclisib Improved Myelofibrosis Symptoms in Patients With Suboptimal Response to Ruxolitinib
At 12 weeks, most patients had a reduction in spleen volume.
Disease Features in Young Patients With Myeloproliferative Neoplasms
Researchers found a high incidence of thromboembolic events in young patients with myeloproliferative neoplasms, especially polycythemia vera.
Myeloproliferative Neoplasms: What Your Patients Need to Know
Myeloproliferative neoplasms (MPN) are a rare form of blood cancer. Though most people don’t know a lot about, approximately 20,000 people develop MPNs each year. Here are the basics you can explain to a concerned patient.
Mortality Risk With COVID-19 in Patients With Myeloproliferative Neoplasms
Observational, retrospective study revealed factors that may be linked to higher mortality risk in patients with MPN and COVID-19.
Carriers of CALR Mutations at Decreased Risk for Thrombotic Events Among Patients With Essential Thrombocythemia
Researchers determined the impact of mutations in the CALR gene on thrombotic risk for patients with essential thrombocythemia.
- Loading...
Loading...
Next post in Multiple Myeloma
Loading... 
Loading...